Latest Posts
Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study
Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a
Starting a vein practice? Start here!
Quality Training All Treatment Modalities You, your staff, your patients in the comfort of your own office. Real hands on training! Our on-site consultant Joyce Vining RVT, LPN 25 years experience treating vein disease. Venous Ultrasound | Endovenous Ablation | Phlebectomy | Sclerotherapy Need Office Forms, Photos, and Patient Education?
FDA Breakthrough Device designation
Cook Medical announced that its Thoraco+ endovascular system has received Breakthrough Device designation from the FDA. The company describes Thoraco+ as a next- generation, off-the-shelf device in the Zenith platform, indicated for patients with thoracoabdominal aortic aneurysms (Crawford classification I-IV). It has four side branches for the celiac, superior mesenteric,
Alucent’s natural vascular scaffolding to be evaluated in ACTIVATE II FIH trial
Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to
Koya Medical’s Dayspring compression system launched for lower extremity treatment of lymphedema and venous disorders
Koya Medical announced the United States commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous diseases in the lower extremities. The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common
AngioDynamics Auryon system to be studied in BTK arteries
AngioDynamics, Inc. announced the launch of a new clinical study assessing the use of the company’s Auryon atherectomy system in the treatment of calcified lesions in below-the-knee (BTK) arteries. The company announced the commercial launch of the Auryon system in Sep. 2020. The investigator-initiated Auryon BTK study will be conducted